Blog

Law360, New York
(January 02, 2014, 8:24 PM ET) -- A California federal judge on Monday upheld a
$2.2 million verdict against Novartis Pharmaceutical Corp.
in a woman's lawsuit over a jaw injury allegedly caused by the bone drugs
Aredia and Zometa, holding the drugmaker had a duty to warn of the risk of
injury.

U.S. District Judge S. James Otero denied Novartis' motion for judgment as a
matter of law as well as a new trial. Plaintiff Adriann Georges sufficiently
showed that Novartis had a duty to warn her of the jaw injury risk and that her
injury was caused both by her use of the drugs and the drugmaker's failure to
warn, according to the judge.

To read the complete article, please click here: law360.com.